.svg)
What Are the Effects of High Folate Levels?
Masking vitamin B12 deficiency: the primary concern
The most clearly established and clinically significant risk of excess folic acid is its ability to correct the macrocytic anemia caused by B12 deficiency, while doing nothing to address the neurological damage that B12 deficiency simultaneously produces. B12 deficiency causes both a characteristic anemia (megaloblastic, with large red cells visible on a CBC as elevated MCV) and progressive peripheral neuropathy and cognitive impairment through demyelination of nerve fibers. Folic acid corrects the anemia, causing a normal-looking CBC, but the neurological deterioration continues unchecked.
This masking effect is the primary reason that testing for B12 status alongside folate is essential in anyone taking folic acid supplements, particularly older adults, vegans, vegetarians, long-term metformin users, and those with malabsorptive conditions. A normal CBC in someone on high-dose folic acid does not exclude B12 deficiency.
Unmetabolized folic acid in circulation
When folic acid intake exceeds the liver's enzymatic capacity to convert it to metabolically active forms, unmetabolized folic acid (UMFA) circulates in the bloodstream. UMFA does not have the same biological function as natural folate metabolites. Research has raised questions about whether chronically elevated UMFA may interfere with folate receptor function and natural killer (NK) cell activity. A 2023 Nordic Nutrition Recommendations scoping review acknowledged ongoing uncertainty about the health implications of UMFA, noting that while evidence for harm is not definitive, high-dose folic acid supplementation in excess of physiological need is not without potential concerns.
Individuals with MTHFR gene variants (particularly the C677T variant) convert folic acid to 5-MTHF more slowly, meaning UMFA may accumulate at lower supplemental doses than in individuals with normal MTHFR function. For those with known MTHFR variants, methylated folate (5-MTHF) is often recommended over synthetic folic acid to bypass this conversion step, though providers should guide this decision.
Potential interactions with cancer biology
The relationship between folate and cancer is complex and bidirectional. Folate deficiency is associated with impaired DNA repair and increased risk of certain cancers, particularly colorectal cancer. Conversely, research has raised questions about whether high folate or folic acid intake in individuals with existing pre-cancerous lesions might promote rather than inhibit tumor growth, by supporting the rapid cell division that cancer cells require. This area of research remains active and the evidence is not settled; it does not establish a clear causal harm from folate at supplement doses, but it is one reason that unnecessarily high doses of folic acid supplementation are generally not recommended in the absence of documented deficiency or pregnancy.
Neurological symptoms
There are reports of neurological symptoms in individuals with very high folate intake alongside B12 deficiency, where folic acid corrects the anemia while the neurological damage progresses. The neurological symptoms (tingling, numbness, gait disturbances, cognitive changes) in this context are attributable to B12 deficiency, not to folate directly. If these symptoms appear in someone taking high-dose folic acid, B12 assessment is urgent.
In the absence of B12 deficiency, there is no well-established symptom complex specifically caused by elevated serum folate at typical supplement doses. The Institute of Medicine has set the tolerable upper intake level for folic acid at 1,000 mcg per day for adults, reflecting the risk of masking B12 deficiency rather than a known direct toxicity.
Which Biomarkers to Assess When Folate Supplementation is Ongoing
- Serum folate — Current folate status; reflects recent dietary intake and supplementation
- RBC folate — Long-term folate status within red cells; more stable than serum measure
- Vitamin B12 — Essential to assess alongside folate; folic acid can mask B12 deficiency
- MCV (Mean Corpuscular Volume) — Red cell size; elevation in B12 deficiency may be masked by folic acid supplementation
- Homocysteine — Elevated when B12 or folate is functionally deficient; useful even when serum B12 appears normal
- Methylmalonic acid (MMA) — Sensitive marker for functional B12 deficiency; elevated even when serum B12 is borderline. Included in the Methylation Panel
Superpower's Methylation Panel includes homocysteine, methylmalonic acid, RBC folate, vitamin B12, vitamin B6, and additional B-vitamin markers that together provide the most complete picture of B-vitamin status, including functional assessment of B12 even when serum levels appear normal. This is the most appropriate panel for anyone on chronic folic acid supplementation.
When High Folate Warrants Attention
An elevated serum folate result on its own, without accompanying symptoms or an abnormal B12 level, does not typically require intervention. The appropriate response is a review of current supplement intake and an assessment of whether the dose is appropriate for the individual's situation.
The scenarios that warrant prompt clinical attention:
- High serum folate with neurological symptoms (tingling, numbness, cognitive changes), even with a normal CBC, as B12 deficiency may be present but masked
- High serum folate in a patient with a known MTHFR variant who is taking synthetic folic acid rather than methylated folate
- Folic acid supplementation in an older adult without concurrent B12 monitoring
- High-dose folic acid supplementation (above 800 to 1,000 mcg per day) without a clinical indication such as neural tube defect prevention in pregnancy
FAQs
There is no well-characterized symptom complex caused directly by elevated serum folate at supplement doses used by most individuals. The primary concern is indirect: high folic acid supplementation can mask vitamin B12 deficiency, allowing neurological symptoms from B12 deficiency (tingling, numbness, cognitive changes) to progress while the CBC appears normal. If these neurological symptoms are present in someone on high-dose folic acid, serum B12, methylmalonic acid, and homocysteine should be assessed.
It is extremely unlikely to achieve clinically elevated serum folate from natural food sources alone. Natural folate from vegetables, legumes, and liver is absorbed at variable and generally lower efficiency than synthetic folic acid, and the forms present in food are metabolized differently. Elevated serum folate is almost always the result of folic acid supplementation or consumption of multiple fortified foods combined with supplementation.
High folic acid does not deplete B12 or cause B12 deficiency. The concern is that it can correct the anemia (macrocytic red cells, low hemoglobin) caused by B12 deficiency while leaving the neurological damage unaddressed. A normal CBC in someone on high-dose folic acid does not rule out B12 deficiency. Serum B12 and functional markers such as methylmalonic acid should be measured directly in this context.
For individuals with MTHFR gene variants that impair folic acid conversion, methylated folate (5-MTHF) is often recommended as it bypasses the conversion step. For individuals without MTHFR variants, folic acid at standard doses is generally well-tolerated and effective. The decision should be made with a provider who has reviewed your genetic and laboratory data. Switching to methylfolate without understanding your baseline status is not a reliable approach.
There is no universally agreed-upon upper threshold for serum folate that defines "too high" in clinical practice. Most laboratories flag results above 20 ng/mL as elevated, though this varies. The clinical significance depends on context: a high serum folate in someone taking supplements is expected and not automatically concerning. It becomes relevant when accompanied by neurological symptoms, low B12, or when the individual is taking doses well above the tolerable upper intake level without a medical indication.
There are anecdotal reports of mood changes, irritability, and anxiety in individuals taking high-dose folic acid, possibly related to its role in neurotransmitter synthesis and methylation. However, these associations have not been consistently established in controlled studies. If mood changes coincide with starting or increasing folic acid supplementation, it is worth discussing with a provider, as the symptom may relate to methylation dynamics, B12 status, or other factors rather than folate alone.
References
- Reynolds, E. H. (2016). What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies. European journal of clinical nutrition, 70(5), 537-40. https://doi.org/10.1038/ejcn.2015.231
- Bjørke-Monsen, A. L., & Ueland, P. M. (2023). Folate - a scoping review for Nordic Nutrition Recommendations 2023. Food & nutrition research, 67. https://doi.org/10.29219/fnr.v67.10258
- Plumptre, L., Masih, S. P., Ly, A., Aufreiter, S., Sohn, K. J., Croxford, R., Lausman, A. Y., Berger, H., O'Connor, D. L., & Kim, Y. I. (2015). High concentrations of folate and unmetabolized folic acid in a cohort of pregnant Canadian women and umbilical cord blood. The American journal of clinical nutrition, 102(4), 848-57. https://doi.org/10.3945/ajcn.115.110783
- Kim, Y. I. (2007). Folate and colorectal cancer: an evidence-based critical review. Molecular nutrition & food research, 51(3), 267-92. https://doi.org/10.1002/mnfr.200600191
- Ledowsky, C., Mahimbo, A., Scarf, V., & Steel, A. (2022). Women Taking a Folic Acid Supplement in Countries with Mandatory Food Fortification Programs May Be Exceeding the Upper Tolerable Limit of Folic Acid: A Systematic Review. Nutrients, 14(13). https://doi.org/10.3390/nu14132715
.avif)
.svg)
.svg)
